BG15220A3 - Метод за получаване на нови заместени 3-амино-4-халогенсиднонимини - Google Patents

Метод за получаване на нови заместени 3-амино-4-халогенсиднонимини

Info

Publication number
BG15220A3
BG15220A3 BG011905A BG1190569A BG15220A3 BG 15220 A3 BG15220 A3 BG 15220A3 BG 011905 A BG011905 A BG 011905A BG 1190569 A BG1190569 A BG 1190569A BG 15220 A3 BG15220 A3 BG 15220A3
Authority
BG
Bulgaria
Prior art keywords
halogencydnonimines
amino
obtaining new
new substituted
substituted
Prior art date
Application number
BG011905A
Other languages
Bulgarian (bg)
English (en)
Inventor
Manfred Goetz
Kurt Freter
Karl Zeile
Original Assignee
Karl Zeile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karl Zeile filed Critical Karl Zeile
Publication of BG15220A3 publication Critical patent/BG15220A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG011905A 1968-03-26 1969-03-25 Метод за получаване на нови заместени 3-амино-4-халогенсиднонимини BG15220A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770061 DE1770061A1 (de) 1968-03-26 1968-03-26 Neue substituierte 3-Amino-4-bromsydnomimine

Publications (1)

Publication Number Publication Date
BG15220A3 true BG15220A3 (bg) 1975-11-21

Family

ID=5700383

Family Applications (1)

Application Number Title Priority Date Filing Date
BG011905A BG15220A3 (bg) 1968-03-26 1969-03-25 Метод за получаване на нови заместени 3-амино-4-халогенсиднонимини

Country Status (18)

Country Link
AT (1) AT285619B (OSRAM)
BE (1) BE730510A (OSRAM)
BG (1) BG15220A3 (OSRAM)
BR (1) BR6907417D0 (OSRAM)
CA (1) CA945990A (OSRAM)
CH (1) CH519511A (OSRAM)
DE (1) DE1770061A1 (OSRAM)
DK (1) DK130296B (OSRAM)
ES (2) ES364979A1 (OSRAM)
FI (1) FI54480C (OSRAM)
FR (1) FR2004770A1 (OSRAM)
GB (1) GB1219254A (OSRAM)
HU (1) HU162735B (OSRAM)
IE (1) IE32708B1 (OSRAM)
IL (1) IL31909A (OSRAM)
NL (1) NL6904632A (OSRAM)
SE (1) SE374746B (OSRAM)
YU (1) YU69369A (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
FR2004770A1 (OSRAM) 1969-11-28
GB1219254A (en) 1971-01-13
YU69369A (en) 1978-09-18
IL31909A (en) 1973-01-30
FI54480C (fi) 1978-12-11
DE1770061A1 (de) 1971-09-16
CH519511A (de) 1972-02-29
HU162735B (OSRAM) 1973-04-28
DK130296B (da) 1975-02-03
BR6907417D0 (pt) 1973-04-12
IE32708B1 (en) 1973-10-31
FI54480B (fi) 1978-08-31
DK130296C (OSRAM) 1975-06-30
CA945990A (en) 1974-04-23
ES376981A1 (es) 1972-05-01
IL31909A0 (en) 1969-05-28
ES364979A1 (es) 1971-02-16
BE730510A (OSRAM) 1969-09-26
SE374746B (OSRAM) 1975-03-17
NL6904632A (OSRAM) 1969-09-30
AT285619B (de) 1970-11-10
IE32708L (en) 1969-09-26

Similar Documents

Publication Publication Date Title
BG17951A3 (bg) Метод за получаване на бета- арил-2- аминоалокси- стироли
BG17750A3 (bg) Метод за получаване на нови 1-фенокси-2-хидрокси-3- циклоалкиламинопропани
BG16183A3 (bg) Метод за получаване на адипонитрил
BG15556A3 (bg) Метод за получаване на 1-халоген-1-формил- карбонил-фенилхидразони
BG17305A3 (bg) Метод за получаване на нови производни р-аминоалкил-бензолсулфон- амида
BG16179A3 (bg) Метод за получаване на нови субституирани фенетилови естери
BG18180A3 (bg) Метод за получаване на нови амино-пропиофенони
BG16035A3 (bg) Метод за получаване на хиназолин-2-тиони
BG17545A3 (bg) Метод за получаване на нови производни на бензолцулфонамида
BG17789A3 (bg) Метод за получаване на базично заместени индохини
BG17584A3 (bg) Метод за получаване на бензи мидазоли
BG17293A3 (bg) Метод за получаване на заместени алкиламинопропан
BG17536A3 (bg) Метод за получаване на заместени ациланилиди
BG17606A3 (bg) Метод за получаване на бензодиазепанови соли
BG17973A3 (bg) Метод за получаване на тетрахидро- бензиадиазепинони
BG15689A3 (bg) Метод за получаване на хиназолин-2-тиони
BG17318A3 (bg) Метод за получаване на n-тритил-имидазоли
BG17597A3 (bg) Метод за получаване на хиназолин-2- они
BG19167A3 (bg) Метод за получаване на хинозолин-2-они-
BG17306A3 (bg) Метод за получаване на нови карденолид-гликозиди
BG17009A3 (bg) Метод за получаване на нови производни на сулфониламида
BG17613A3 (bg) Метод за получаване на нови 5- нитрофурилови производни
BG17757A3 (bg) Метод за получаване на нови заместени полиметилендиамини
BG17556A3 (bg) Метод за получаване на заместени 2- азабициклоалкани
BG17605A3 (bg) Метод за получаване на бензадиазепинови соли